No abstract

In this study, we synthesized polynorbornene (PNB) dicarboximides substituted by monochlorophenyl group (PMCPhNDI) and dichlorophenyl group (PDCPhNDI) via ring‐opening polymerization using a ruthenium catalyst and investigated their thermal, mechanical, and optical properties. We also discussed the performance and application of the functionalized PNB dicarboximide films as flexible substrates for organic light‐emitting devices (OLEDs). The polymer films exhibited good optical transparency with an average transmittance of around 97% in the visible light region and good thermal stability with a 5% degradation temperature of >440°C. The polymers were applied for flexible displays, which were coated on indium tin oxide (ITO) thin films using a radio‐frequency planar magnetron sputtering system with changing the deposition substrate temperatures. A flexible OLED that was fabricated on the ITO‐grown polymer substrates exhibited a performance as comparable to the corresponding ITO‐grown glass substrates. Copyright © 2012 John Wiley & Sons, Ltd.

We have fabricated the flexible organic light-emitting diode (OLED) displays on 10 µm colorless polyimide (CPI) substrate using polymer light-emitting diode (PLED). The CPI was chosen as a substrate for flexible device because of its high transparency of around 90% at 550 nm and relatively high temperature process of >300 • C. All organic materials for OLED were deposited by spin coating technique and the OLED on PI substrate was encapsulated by the polyethylene terephthalate (PET) film with barrier layer. The PLEDs have a driving voltage of 3 V at 1000 cd/m 2 , and the current efficiency of 11.7 cd/A for the device on CPI substrate at 1000 cd/m 2 .

Purpose:To report a case of uveitis in both eyes caused by Sweet's syndrome. Case summary: A 66-year-old male presented with decreased visual acuity in his left eye. Three years prior he was diagnosed with Sweet's syndrome, with symptoms such as chill, fever and, maculopapular rash on the chest. At initial physical examination, he had 3 or 4+ inflammatory cells and flare in the anterior chambers of both eyes, as well as hypopyon in his left eye. Under the suspicion of uveitis caused by Sweet's syndrome, he was rescribed an IV steroid injection and topical steroid agent. Three days later, his visual acuity improved to 0.3 in the right eye and 0.2 in the left eye. Hypopyon in the left eye disappeared and inflammatory cells decreased to 1~2+. He showed signs of recurrence in both eyes after 5 months and was treated with posterior subtenon triamcinolone injection in each eye. The patient showed no signs of recurrence for 10 months after injection. Conclusions:We report a case of uveitis caused by Sweet's syndrome treated with a steroid agent resulting in good prognosis. To the best of our knowledge, this is first case of uveitis caused by Sweet's syndrome reported in Korea.